Cancer Vaccines

Known as: vaccines cancer, Tumor Vaccine, Cancer Vaccines [Chemical/Ingredient] 
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1968-2017
010020019682017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The finding that individual cancers contain many mutant genes not present in normal tissues has prompted considerable interest in… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Cancer vaccines targeting 'self' antigens that are expressed at consistently high levels by tumor cells are potentially useful in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE Allogeneic granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting tumor vaccines can cure established tumors… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Tumor-specific immune tolerance limits the effectiveness of cancer vaccines. In addition, tumor vaccines alone have a limited… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The outcome of antigen recognition by naive CD8+ cytotoxic T lymphocytes (CTLs) in the periphery is orchestrated by CD4+ T-helper… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1999
Highly Cited
1999
'Naked' nucleic acid vaccines are potentially useful candidates for the treatment of patients with cancer, but their clinical… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The success of cancer gene therapy is likely to require the targeting of multiple antitumor mechanisms. One strategy involves the… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transduced, irradiated tumor vaccines induce potent, T-cell… (More)
  • table I
  • table 2
  • table 3
  • table 4
  • figure I
Is this relevant?
Highly Cited
1996
Highly Cited
1996
HER-2/neu, an overexpressed oncogenic protein, has been proposed as a human cancer vaccine target. HER-2/neu is a "self" protein… (More)
  • figure 2
  • table I
  • figure 1
  • figure 3
  • figure 4
Is this relevant?